Dysport
通用名称
abobotulinumtoxinA
儿科标签批准日期
2020/7/8 0:00:00
特定指示/秒
Upper limb spasticity in pediatric patients 2 to 17 years
标签更改摘要
- Safety and effectiveness have been established by evidence from adequate and well-controlled studies in patients 2 years and older with upper limb spasticity. - Safety and effectiveness in pediatric patients below the age of 2 years have not been established. - Information on safety profile, and clinical study. - Postmarketing requirement.
治疗类别
Spinal Cord Injury
立法类型
PREA Only
产品说明书链接
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3